LT - INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
EN - INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/4965 |
(2006.01) |
|
|
A61K 31/4985 |
(2013.01) |
|
|
A61K 31/4985 |
(2006.01) |
|
|
A61K 31/4965 |
(2013.01) |
|
|
A61K 31/505 |
(2006.01) |
|
|
A61K 31/53 |
(2013.01) |
|
|
A61K 31/506 |
(2006.01) |
|
|
A61K 31/519 |
(2013.01) |
|
|
A61K 31/519 |
(2006.01) |
|
|
A61K 31/505 |
(2013.01) |
|
|
A61K 31/53 |
(2006.01) |
|
|
A61K 31/506 |
(2013.01) |
|
|
A61P 9/12 |
(2006.01) |
|
|
A61P 9/12 |
(2018.01) |
|
|
A61K 45/06 |
(2006.01) |
|
|
A61K 45/06 |
(2013.01) |
|
|
Y02A 50/30 |
(2018.01) |
European patent
(11) |
Number of the document |
4065119 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
20820054.3 |
|
Date of filing the European patent application |
2020-11-27 |
(97) |
Date of publication of the European application |
2022-10-05 |
(45) |
Date of publication and mention of the grant of the patent |
2024-09-04
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/EP2020/083593 |
|
Date |
2020-11-27 |
PCT application publication
(87) |
Number |
WO 2021/105331 |
|
Date |
2021-06-03 |
Priority applications
(30) |
Number |
Date |
Country code |
|
201962941910 P |
2019-11-29
|
US |
|
202063023452 P |
2020-05-12
|
US |
|
202063076149 P |
2020-09-09
|
US |
Inventors
(72) |
MARESTA, Alessandro , CH
PERCHENET, Loïc , CH
|
Grantee
(73) |
Actelion Pharmaceuticals Ltd ,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
Title
(54) |
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION |
|
INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION |